Black Diamond Therapeutic's Cash, Cash Equivalents, And Investments Of $112.7M As Of September 30, 2024; Expected To Be Sufficient To Fund Operations Into Q2 Of 2026
Black Diamond Therapeutic's Cash, Cash Equivalents, And Investments Of $112.7M As Of September 30, 2024; Expected To Be Sufficient To Fund Operations Into Q2 Of 2026
Black Diamond Therapeutic的現金、現金等價物和投資截至2024年9月30日爲11270萬美元;預計可支持經營至2026年第二季度
Black Diamond Therapeutic's Cash, Cash Equivalents, And Investments Of $112.7M As Of September 30, 2024; Expected To Be Sufficient To Fund Operations Into Q2 Of 2026
Black Diamond Therapeutic的現金、現金等價物和投資截至2024年9月30日爲11270萬美元; 預計將足夠支持運營至2026年第二季度
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。